Kambiz Yazdi
Stock Analyst at BTIG
(4.69)
# 361
Out of 5,182 analysts
24
Total ratings
87.5%
Success rate
25.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $39.51 | +46.80% | 5 | Apr 27, 2026 | |
| RAPP Rapport Therapeutics | Reiterates: Buy | $53 | $33.83 | +56.67% | 4 | Apr 22, 2026 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $843 | $322.69 | +161.24% | 6 | Apr 6, 2026 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $23 | $9.93 | +131.62% | 1 | Mar 16, 2026 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $49 | $29.50 | +66.10% | 3 | Mar 11, 2026 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $14.29 | +60.95% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $23.25 | -18.28% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $13.61 | +10.25% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.44 | +248.43% | 1 | Apr 12, 2024 |
Sionna Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $58
Current: $39.51
Upside: +46.80%
Rapport Therapeutics
Apr 22, 2026
Reiterates: Buy
Price Target: $53
Current: $33.83
Upside: +56.67%
Praxis Precision Medicines
Apr 6, 2026
Reiterates: Buy
Price Target: $843
Current: $322.69
Upside: +161.24%
Zevra Therapeutics
Mar 16, 2026
Initiates: Buy
Price Target: $23
Current: $9.93
Upside: +131.62%
vTv Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $49
Current: $29.50
Upside: +66.10%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $14.29
Upside: +60.95%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $23.25
Upside: -18.28%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $13.61
Upside: +10.25%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.44
Upside: +248.43%